Unlocking the Future of the Emerging Infectious Disease Diagnostics Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
What fueled the previous growth in the emerging infectious disease diagnostics market?
The market size of emerging infectious disease diagnostics has seen impressive growth in past few years. The market is anticipated to expand from $22.13 billion in 2024 to $24.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.0%. The prior period growth is attributed to factors such as a higher demand for point-of-care diagnostics, increased occurrence of infectious diseases, increase in global population density, rising instances of infectious diseases, and heightened expenditure in healthcare.
What will be the emerging infectious disease diagnostics market size in the future?
In the forthcoming years, a robust surge is anticipated in the emerging infectious disease diagnostics market, with the market size slated to hit $35.21 billion in 2029 at a 9.7% compound annual growth rate (CAGR). This predicted growth during the forecast period can be linked to factors such as the increasing occurrence of zoonotic diseases, considerable changes and support in regulation, the development of all-encompassing vaccines, the escalating focus on a single health approach, and enhanced governmental support and funding. The foreseen period will also experience key trends, which will include technological progress, next-generation sequencing (NGS), isothermal amplification methods, telemedicine, and remote diagnostics along with monitoring of environmental pathogens.
Get your emerging infectious disease diagnostics market report here!
What main drivers are fueling expansion in the emerging infectious disease diagnostics market?
The escalating frequency of diseases that transmit from animals to humans, known as zoonotic diseases, is projected to fuel the growth of the emerging infectious disease diagnostics market in the future. The increase in zoonotic diseases is primarily attributed to greater interactions between humans and wildlife, habitat devastation, and international travel, which encourage the spread of pathogens beyond species. Early detection and precise pathogen identification are made possible through emerging infectious disease diagnostics, enabling swift intervention, effective treatment, and superior disease outbreak management, thus minimizing animal-to-human transmission. For example, as per the 2022 Zoonotic Disease Report released by the State of West Virginia, a US government entity, in the MMWR Year 2022, there was a significant increase in reported Lyme disease cases, with a total of 2,449 cases, a substantial rise from 1,788 cases in 2021. As a result, the escalation of zoonotic diseases is significantly contributing to driving the emerging infectious disease diagnostics market.
What key areas define the segmentation of the global emerging infectious disease diagnostics market?
The emerging infectious disease diagnostics market covered in this report is segmented –
1) By Infection Type: Viral, Bacterial, Fungal, Other Infections
2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies
4) By Application: Laboratory Testing, Point-of-Care Testing
5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users
Subsegments:
1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections
4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20548&type=smp
Who are the dominant players expanding their reach in the emerging infectious disease diagnostics market?
Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.
How are evolving market trends shaping emerging infectious disease diagnostics Strategies?
Leading businesses within the burgeoning field of emerging infectious disease diagnostics are turning their focus towards enhanced technologies like molecular diagnostic platforms for gaining a competitive edge. Molecular diagnostic platforms employ nucleic acid amplification methods that detect pathogens with high accuracy and specificity, facilitating precise diagnosis and early disease detection. For example, Becton Dickinson and Company, a medical equipment manufacturing firm from the US, introduced the BD COR MX/PX System in May 2022. This fully automated, high-throughput diagnostic platform enhances lab efficiency by automating the entire molecular workflow, from processing of samples to results generation. Its inaugural assay, the BD CTGCTV2, helps identify three common non-viral sexually transmitted infections (STIs). With onboard reagent and sample capacity, the BD COR MX/PX System can handle up to 1,700 specimens, ensuring over seven hours of uninterrupted operation and delivering up to 1,000 results within a 24-hour frame, thus significantly cutting down manual handling by lab staff.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20548
Which regions are emerging as leaders in the emerging infectious disease diagnostics market?
North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Point-of-Care Diagnostics Devices and Equipment Global Market Report 2025
Transplant Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Analysis of Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
